CTI BioPharma Corp. | Cash Flow
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
55,736.00
94,229.00
120,763.00
51,065.00
49,209.00
29,352
Depreciation, Depletion & Amortization
1,570.00
1,100.00
990.00
831.00
717.00
593
Other Funds
244.00
102.00
439.00
325.00
113.00
1,976
Funds from Operations
32,907.00
49,233.00
102,659.00
68,104.00
33,124.00
26,783
Changes in Working Capital
2,923.00
9,683.00
7,456.00
8,576.00
6,172.00
13,041
Net Operating Cash Flow
35,830.00
39,550.00
95,203.00
76,680.00
39,296.00
39,824
Capital Expenditures
1,657.00
333.00
78.00
137.00
49.00
Sale of Fixed Assets & Businesses
123.00
-
-
-
-
Net Investing Cash Flow
1,534.00
541.00
78.00
137.00
38.00
Issuance/Reduction of Debt, Net
14,501.00
1,911.00
6,161.00
6,727.00
19,548.00
Net Financing Cash Flow
58,972.00
36,026.00
152,017.00
7,366.00
38,979.00
Net Change in Cash
21,203.00
706.00
57,249.00
84,180.00
784.00
Free Cash Flow
37,487.00
39,883.00
95,281.00
76,817.00
39,345.00
Other Sources
-
-
-
-
11.00
Change in Capital Stock
44,715.00
32,487.00
146,295.00
314.00
58,640.00
Exchange Rate Effect
405.00
3,359.00
513.00
3.00
429.00
Other Uses
-
208.00
-
-
-
About CTI BioPharma
View Profile
